Atualização Científica >> Destaques de Revistas

OMEGA, a randomized, placebo-controlled trial to test the effect of highly purified omega-3 fatty acids on top of modern guideline-adjusted therapy after myocardial infarction

Rauch B, Schiele R, Schneider S, Diller F, Victor N, Gohlke H, et al; OMEGA Study Group. Circulation. 2010 Nov 23;122(21):2152-9.

Influence of age on associations between childhood risk factors and carotid intima-media thickness in adulthood: the Cardiovascular Risk in Young Finns Study, the Childhood Determinants of Adult Health Study, the Bogalusa Heart Study, and the Muscatine Study for the International Childhood Cardiovascular Cohort (i3C) Consortium.

Holme I, Aastveit AH, Hammar N, Jungner I, Walldius G. Atherosclerosis. 2010 Nov;213(1):299-305.

Ten-year follow-up survival of the Medicine, Angioplasty, or Surgery Study (MASS II): a randomized controlled clinical trial of 3 therapeutic strategies for multivessel coronary artery disease.

Santos RD.Atherosclerosis. 2010 Oct;212(2):390-1.

Inflammation, coronary artery calcification and cardiovascular events in incident renal transplant recipients.

Roe P, Wolfe M, Joffe M, Rosas SE. Atherosclerosis. 2010 Oct;212(2):589-94.

Cholesterol embolization syndrome.

Kronzon I, Saric M. Circulation. 2010 Aug 10;122(6):631-41.

Interventions to promote physical activity and dietary lifestyle changes for cardiovascular risk factor reduction in adults: a scientific statement from the American Heart Association. /h3>

Artinian NT, Fletcher GF, Mozaffarian D, Kris-Etherton P, Van Horn L, Lichtenstein AH, et al; American Heart Association Prevention Committee of the Council on Cardiovascular Nursing.

Desenvolvido pela Diretoria de Tecnologia da SBC
Todos os Direitos Reservados © Copyright 2015
Sociedade Brasileira de Cardiologia | Tecnologia@cardiol.br